Longeveron (LGVN) Current Deferred Revenue (2021 - 2026)
Longeveron's (LGVN) quarterly Current Deferred Revenue came in at $102000.0 in Q1 2026, up 155.0% quarter-over-quarter from $40000.0 in Q4 2025.
Longeveron (LGVN) Current Deferred Revenue (2021 - 2026) Analysis & Trends
Longeveron's Current Deferred Revenue history runs 6 years deep, the most recent figure standing at $102000.0 for Q1 2026.
- On a quarterly basis, Current Deferred Revenue changed N/A year-over-year to $102000.0 in Q1 2026; TTM through Mar 2026 was $102000.0, a N/A change from a year earlier, with the FY2025 full-year figure at $40000.0, changed 0.0% from the prior year.
- Current Deferred Revenue rose to $102000.0 in Q1 2026 per LGVN's latest filing, from $40000.0 in the prior quarter.
- Across five years, Current Deferred Revenue topped out at $506000.0 in Q4 2022 and bottomed at $0.1 in Q2 2024.
- The 5-year median for Current Deferred Revenue is $100000.0 (2022), against an average of $128769.2.
- Across the five-year window, Current Deferred Revenue tumbled 100.0% in 2024 and surged 39999900.0% in 2025, its largest moves.
- Year by year, Current Deferred Revenue stood at $506000.0 in 2022, then changed by 0.0% to $506000.0 in 2023, then plunged by 92.09% to $40000.0 in 2024, then changed by 0.0% to $40000.0 in 2025, then jumped by 155.0% to $102000.0 in 2026.
- Per Business Quant, the three latest LGVN Current Deferred Revenue figures stand at $102000.0 (Q1 2026), $40000.0 (Q4 2025), and $40000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Longeveron | 3.97 Mn | -11.79 Mn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 102,000.00 |
| Dec 31, 2025 | 40,000.00 |
| Sep 30, 2025 | 40,000.00 |
| Jun 30, 2025 | 40,000.00 |
| Dec 31, 2024 | 40,000.00 |
| Sep 30, 2024 | 0.10 |
| Jun 30, 2024 | 0.10 |
| Dec 31, 2023 | 506,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Dec 31, 2022 | 506,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Dec 31, 2021 | 199,000.00 |